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Abstract Systems Biology is a rapidly developing discipline which utilises math-
ematical and computer science techniques to analyse and interpret biological
models. Petri nets have been proposed as an effective formalism for Systems
Biology but so far only a small number of simple manual Petri net models have
been constructed and investigated. In this paper we present a scheme for automat-
ically mapping biological systems into Petri net models using XML technology.
We develop a simple prototype tool which translates Systems Biology Markup
Language (SBML) to the Petri Net Markup Language (PNML). As an illustrative
example we consider mapping a SBML description of the Saccharomyces cere-
visiae glycolysis pathway into PNML. An analysis of the resulting PNML model
then demonstrates that even basic invariant analysis can produce interesting re-
sults for biologists. Finally we discuss what features may be desirable to systems
biologists in future modifications of the PNML standard.
1 Introduction
Advances in high-throughput molecular biology have resulted in an explosion in the
data available to biologists. The ever increasing number of complete genome sequences,
together with data arising from post-genomic studies makes the study of cellular sys-
tems at a global level a reality. Systems Biology [14] has arisen as a fast developing dis-
cipline that employs statistical, mathematical and computer science methods, together
with wet, laboratory based research, to assemble, analyse and investigate models of bi-
ological systems at a holistic level. Research in this area is already producing valuable
information about biological systems. With sciences current trend towards interdisci-
plinary collaboration it is becoming increasingly desirable to transfer models from one
formalism to another and this is especially true of Systems Biology. To aid the transfer
of this information a standard XML format for information interchange, SBML (Sys-
tems Biology Markup Language) [8] is being developed. Further techniques and tools
are now required to exploit the expanding SBML data repositories available, such as
the KEGG database [10].
Petri nets [21] are a well supported formal framework for modelling and analysing
complex concurrent systems. Petri nets have a proven track record in modelling com-
puting systems and a wide body of literature and tools are available on such methods,
see [3,1,31]. Petri nets have recently been proposed as a potential tool for modelling,
composing and analysing biological systems. To date a number of initial investigations
2have appeared in the literature including the application of place transition nets (P/T
nets) [22], stochastic nets [4], coloured nets [7] and hybrid nets [16]. However, these
initial investigations have so far centered on the manual, expert translation of biologi-
cally systems in to the Petri net framework and are thus only feasible for the smallest
examples. A method to automatically import biological information for Petri net analy-
sis is now required to allow realistically large biological systems to be investigated.
In this paper we present a scheme for automatically mapping biological systems
into Petri net models using XML technology. XML [19] is a platform independent in-
formation interchange format. The use of XML based languages as standards to transfer
information and models between tools and disciplines is developing quickly. Languages
such as Math-ML [29] and SBML [8] are in current use and are being continually de-
veloped. The Petri Net Markup Language (PNML) [30] has recently been formalised
as a standard representation of Petri net models. The ability XML provides to transfer
models between tools maximizes the analysis that can be carried out on a model, while
extending its life beyond the time a particular tool becomes obsolete. We propose a di-
rect mapping from SBML to PNML which serves as a starting point for the Petri net
analysis of biological systems. Since both SBML and PNML are still developing our
aim is to give an insight into what is currently possible and to consider what further
features may be required to enhance the usefulness of PNML in such a translation role.
We illustrate our approach using a SBML example of a simple biological pathway, the
Saccharomyces cerevisiae glycolysis pathway [27] (Figure 2), whose SBML represen-
tation is available at [23]. This pathway metabolises glucose to produce the cellular
energy sources ATP and NADH. We show how this SBML representation of the path-
way can be mechanically translated into a corresponding PNML representation using a
prototype Java based tool. We then analyse the resulting Petri net model and relate the
results back to the initial biological system.
We propose and discuss several ideas to build on and facilitate the use of PNML
for constructing and analysing models imported from SBML. We propose extensions to
the mapping to allow the simulation of a model or view the network in a conceptually
different way. We consider the benet of allowing markup languages to be able to recog-
nise specic tags from other markup languages. For example, a tool may primarily deal
with Generalized Stochastic Petri Nets (GSPN) but may also be able to recognise Math-
ML to allow for a different sampling policy for ring rates. Another important issue is
tracking the evolution of a Petri net model of a biological system. A biologists needs
to be able to discover the original data sources for the Petri net model and also be able
to trace how additional information, such as ring rates in a Stochastic model, were
derived. We discuss the problem of graph layout for automatically generated PNML
models and the provisions needed in the PNML language for this. Finally we consider
what support is needed to allow the modular development of PNML models.
The paper is structured as follows. In Section 2 we present background informa-
tion on Systems Biology and its associated standard markup language SBML. We then
briey consider the applicability of Petri nets to biological modelling. In Section 3
we present a scheme for directly mapping biological systems expressed in SBML into
PNML models. We illustrate this scheme by applying it to an example SBML bio-
logical pathway and then analysing the resulting Petri net model. Section 4 discusses
3the insight gained during this research on PNML and proposes some further ideas for
enhancing PNML to facilitate its use as an interdisciplinary research tool, such as in
Systems Biology. Finally, we present our concluding remarks in Section 5.
Note for brevity, we assume in the sequel that the reader is familiar with the basic
ideas of PNML (see [30] and [31] for an introduction).
2 Background
In this section we present an overview of Systems Biology and the Systems Biology
Markup Language (SBML). We describe the components of SBML and how these make
up a biological model. We then consider how Petri nets can be applied in Systems
Biology and present a brief overview of what has been achieved in Systems Biology
with Petri nets to date.
2.1 Systems Biology and SBML
Advancing techniques in the eld of Molecular Biology have led to an explosion in the
data available. This data now gives a global view of cellular and metabolic function. The
eld of Systems Biology [14] has arisen based on the use of this holistic data to strive to
model and understand how subcellular and multicellular systems interact and operate.
Systems Biology seeks to understand the functional roles of modules or systems, rather
than focusing on their individual components.
Typically, Systems Biology relies on iterative cycles of computer based model con-
struction, renement and prediction, closely coupled to wet-lab experimental design,
experimentation and data storage. Standards are required at both stages of the cycle to
ensure that models are accurately constructed from experimental data. Thus, the stan-
dardisation of the software and modelling procedures is a separate, but very necessary
issue, aside from the standardisation of experimental procedures and data. A number
of world-wide projects are now in place to develop standard computational modelling
software and platforms at the levels of the networks, the components, the model descrip-
tions and for data storage and retrieval [23]. One goal of Systems Biology researchers
is to provide tools and data standards that will facilitate the use of combinations of dif-
ferent modelling techniques and procedures. The Systems Biology Markup Language
(SBML) is a standard format (currently implemented in XML) for the representation of
models of biological networks that has arisen to try to meet this goal [8]. The SBML
has had two ofcial levels released since its conception and is still rapidly maturing.
SBML representations of models developed for a variety of biological systems are now
available from the SBML website [23] (for example ECell [28]) and SBML support
from the Systems Biology modelling community is growing. A test suite of SBML
models has been made available to test modelling techniques and to facilitate SBML
related application developments. Modelling packages that support SBML are able to
parse the SBML le and map it to their own internal format. Although SBML is aimed
at machine readability it is also reasonably easy to follow by eye.
SBML has a simple set of building blocks to represent biological systems at its core.
A number of key components are located at the top level of SBML forming the basis of
4the language. Three components are aimed at dening the entities involved in a reaction
and allow the structure of the model to be represented:
– Species: These are the substances (for example ions, metabolites or proteins) that
take part in a reaction.
– Reaction: Describes the transformation process that change concentration of the
species involved in a reaction. For example, the reaction could describe how reac-
tants form products. Reactions can possess rate parameters that describe the rate of
the transformation process.
– Compartment: A compartment species a nite container for species or substances.
Examples could include the cell or cellular compartments such as the nucleus.
Further components allow the behavioural characteristics of the model to be captured:
– Functional definitions allow functions for a model to be dened.
– Unit definitions specify the units for the quantities used in the model.
– Parameters are quantities possessing a symbolic name that describe the variables
that relate to individual reactions or act a global level.
– Rules are mathematical expressions that dene how variables are calculated and
constrained.
– Events describe the changes in sets of variables that may be triggered when a certain
condition becomes satised.
An example of how a biological reaction may be captured using SBML is shown in
Figure 1. The reaction in which Glucose is converted to Glucose-6-phosphate is shown
...
<listOfSpecies>
  <species name=“Glucose” compartment=“uVol”
initialAmount=“0.086999”/>
  <species name=“Glucose-6-phosphate” compartment=“uVol”
initialAmount=“1.39”/>
...
</listOfSpecies>
…
<listOfReactions>
 <reaction name=“R1” reversible=“false”>
<listOfReactants>
<species Reference species=“Glucose” stochemistry=“1” />
<species Reference species=”ATP” stochemistry=”1"/>
</listOfReactantss>
<listOfProducts>
<species Reference species=“Glucose-6-phosphate” stochemistry=“1” />
<species Reference species=”ADP” stochemistry=”1"/>
</listOfProducts>
</reaction>
...
Glucose
Glucose-6-phosphate
ATP
ADP
Figure 1. Conversion pathway of Glucose to Glucose-6phosphate and its SBML representation.
as a traditional biological diagram and represented in SBML (although some of the tags
5have been omitted for clarity). In this simple reaction glucose is converted to glucose-
6-phosphate, using ATP as an energy source. Hence the reactants are Glucose and ATP,
the products are Glucose-6-phosphate and ADP. There are often enzymes associated
with reactions in biological systems, these catalyse the reaction, speeding it up, and
effectively allow the reaction to proceed. Currently SBML allows a <modifier> to be
associated with a reaction, however there is no distinction between an enzyme or an
inhibitor of a reaction. We hope that this will be resolved in future revisions allowing a
more accurate, structural view of the system.
2.2 Petri Nets in Systems Biology
Biological molecular systems may be viewed as complex concurrent processes. Cellular
mechanisms are complex and dynamic, multiple genes are transcribed, multiple types
and copies of transcripts are translated to proteins, and those proteins partake in multiple
signalling processes and metabolic reactions in a concurrent fashion. Petri net models
have evolved to model complex concurrent computing systems in a discrete fashion
and hence are inherently suitable for modelling biological networks in Systems Biology
applications. For example, Figure 2 shows a complex system depicting the glycolysis
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Figure 2. The Saccharomyces cerevisiae glycolysis pathway [27]
pathway in Saccharomyces cerevisiae [11] , with examples of concurrency and choice,
demonstrating the similarity to traditional problems modeled as Petri nets. To date, there
have been a limited number of initial reports into the use of Petri nets models in Systems
Biology. P/T nets have been used to analyse a biological pathways in an erythrocyte cell
[22]. Stochastic Petri nets have been used to model regulatory pathways in E.coli [25],
blood coagulation [20] and COLE1 plasmid replication [4]. Coloured Petri nets have
also been utilised as an avenue for investigation of biological pathways [7].
There are two aspects of biological networks that can be represented and analysed
using Petri net based models:
6– Network structure. Network structural properties can be analysed using methods al-
ready devised for the structural analysis of Petri nets. Some progress has been made
in this area already, for example the use of Place and Transition invariants [22], al-
though there are many interesting net properties such as boundedness, liveness and
reachability for which a biological context still remains to be investigated.
– Network behaviour. Individual cellular processes can be viewed as discrete event
systems in which sets of single molecules act as species, products and mediators
in these reactions and processes. Hence, the concentrations of these entities can ul-
timately be expressed as integer units. The behaviour of biological networks over
time has been modeled with stochastic [15] and hybrid Petri nets [16]. When sim-
ulating a network over time the rates of the reaction must be captured. Currently
these rates are obtained from a combination of experimental results, expert knowl-
edge and experimentally manipulating the network representation.
At present the structure and behavioural aspects of the Petri net models described in the
literature have generally been encoded by hand, using expert knowledge. This is a time
consuming and error prone process that may involve the duplication of models that have
already been dened in a different modelling environment. The advent of SBML as a
common model description language now makes it feasible to generate Petri net models
from classical biological networks modelled by other means. A method to generate Petri
net models from SBML would open up Petri net modelling techniques for application
to many biological networks that have already been predened and veried.
3 Mapping SBML to PNML
In this section we consider in detail the mapping between SBML and PNML models.
We begin by describing how an SBML model can be directly mapped to a PNML de-
scription of a P/T net in which each token represents the presence of one molecule of
a given species. We then consider alternatives ways of modelling biological systems
with Petri nets and in particular, discuss how the basic PNML P/T net mapping can be
extended to produce safe Petri net and stochastic Petri net models. We conclude this
section by considering how existing Petri net tools can be used to analyse a PNML
description of a biological system.
3.1 Mapping from SBML to a P/T Net
In this section we view biological pathways as a series of parallel discrete events, where
one molecule of a substance is deemed equivalent to a single token [22]. Using this
simple approach we show how an SBML model can be directly mapped to a PNML
description of a P/T net. We illustrate the mapping we propose using the Saccharomyces
cerevisiae glycolysis pathway introduced in Section 2.
Each SBML le will contain a list of species which take part in the biological reac-
tions of the system in question. Each species is specied using a <species> eld which
contains a unique <ID> attribute which names the species, a <compartment> eld iden-
tifying where the the given species is found, and an <initialConcentration> eld.
7Each species will be represented by a place in our Petri net model and mapped to a
PNML <place> eld. The species <ID> attribute then becomes the place <ID> attribute
and <name> eld. For example the following PNML would be used to represent the
species glucose given in Figure 1.
<place ID=glucose>
<name>
<text>glucose</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
One added complication is that a species may occur in more than one compartment
in an SBML model. In this case it is clear why the <ID> attribute must be used as
the identier. The information about the compartment may be retained as part of the
modular or graphical elements (see Section 4). The initial concentration eld will be
used to calculate the Petri nets initial marking and we discuss this in more detail below.
In an SBML le the <reaction> eld is used to specify a single reaction that
takes certain species as inputs, as specied by the <listOfReactions> eld and pro-
duces certain species as products, specied by the <listOfProducts> eld. Each
reaction will be represented by a transition in the Petri net model using the PNML
<transition> eld and the unique <ID> attribute associated with each SBML reac-
tion map to the <ID> attribute of the corresponding transition. We then need to dene
the arcs that will be used to connect the input/output places to the newly created PNML
transition. We create an <arc> entry from each species place in the list of reactants to
the new transition and from the transition to each species place in the list of products.
Note that in SBML there is no concept similar to an arc so to satisfy the naming re-
quirements of PNML each arc is given an <ID> Ai where i is an integer that relates to
the order in which the arcs are created, (calculated as a global counter) and A represents
arc. A simple example Figure 3 shows how the reaction shown in Figure 2 is mapped
Threhalose
G6P
ADP
ATP
2
- <reaction name="vTreha" reversible="false">
- <listOfReactants>
<specieReference specie=" G6P" stoichiometry="2" />
<specieReference specie=" ATP" stoichiometry="1" />
</listOfReactants>
- <listOfProducts>
<specieReference specie=" Trh" stoichiometry="1" />
<specieReference specie=" ADP" stoichiometry="1" />
</listOfProducts>
…….
</reaction>
Figure 3. Creation of a simple transition from SBML.
to a transition in PNML. A reaction tag may have the <reversible> eld set to true
8to indicate that the reaction can also occur in the reverse direction. If this is the case
then we create a second transition for the reaction which we name ID_R (where ID is
the original reaction <ID>) such that the input/output places of the original transition
are reversed. An example of such a Petri net for a reversible reaction and the associated
SBML fragment is given in Figure 4.
BPG
NADH
NAD
GAP
- <reaction name="vGAPDH" reversible="true">
- <listOfReactants>
<specieReference specie="GAP" stoichiometry="1" />
<specieReference specie="NAD" stoichiometry="1" />
</listOfReactants>
- <listOfProducts>
<specieReference specie="BPG" stoichiometry="1" />
<specieReference specie="NADH" stoichiometry="1" />
</listOfProducts>
…….
</reaction>
Figure 4. How a reversible reaction is mapped
Given the Petri net structure we now need to derive the initial marking for the PNML
model. We set the <initialMarking> attribute in PNML using either the SBML species
<initialAmount> or <initialConcentration> elds. The <initialAmount> eld
defaults to dene the initial quantity of the species as a molar amount [8], if however
a <substanceUnits> eld is dened <initialAmount> is then dened in terms of
that unit. If the value is in a molar form then the <initialMarking> can be obtained
simply by multiplication by Avogadro’s number. If the <substanceUnits> are a mul-
tiplication of a molar amount then a simple conversion can be carried out to obtain
the molecular amount. In the unlikely event that the <substanceUnits> are not in a
molar form then more user input is required. The <initialConcentration> eld rep-
resents the concentration of a substance and can only be used if a volume is assigned
to a compartment. The units used in the <initialConcentration> eld take the form
of <substanceUnits>/<spatialUnits>. (Note <initialConcentration> has only
been included since the recent level 2 revision in SBML.) If the specied initial con-
centration is in a mole/litre amount then the molecules can be obtained by assuming
one molecule is equal to 1nM [25]. In the unlikely event that mole/litre concentra-
tions are not used then more user input is required. The <initialConcentration>
and <initialAmount> elds are mutually exclusive. If either of these elds is empty
then it is implied that the values are unknown or are not needed for the analysis. If the
values are missing from a SBML le then the <initialMarking> is set to 0.
The above mapping from SBML to a PNML model has been implemented as a
prototype Java tool using JDOM [9]. JDOM was chosen due to its simplicity and plat-
form independence, a JDOM/Java based tool will run on any system with a Java vir-
9tual machine. This simple conversion tool is available on request from the authors. See
www.bioinformatics.cs.ncl.ac.uk for more details.
3.2 Extending the Mapping to Other Net Types
Given the above view of an SBML system where tokens directly represent molecules
and reactions are seen as discrete events we can always derive a P/T net model using the
SBML to PNML mapping described. However, the proposed mapping is clearly not the
only way a biological system can be modelled with Petri nets. For example instead of
viewing the system as purely discrete it may be viewed as hybrid [16], with some places
and transitions discrete and some continuous. This allows real values of concentrations
to be used instead of discrete number of molecules. It is also possible to add time and
quantitatively simulate the network. Stochastic effects have proven to be an important
part of biological systems [17], and simulating a network in a stochastic manner would
be benecial. Another possible view is to consider biological pathways as Boolean
networks where substances are denoted as present or absent depending on whether the
current concentration meets a threshold requirement. Such a view leads naturally to a
safe Petri net model in which structural analysis is simplied and inhibiting reactions
can be easily modelled. In this section we briey consider how our mapping could be
extended to obtain safe Petri net and stochastic Petri net representations of biological
systems.
In many biological systems researchers are interested in analysing the behavior of
the system over time. Stochastic Petri nets [15] provide one means of modelling time
information and have already been used to model biological systems (see for example
[4,25]). Stochastic Petri nets are essentially P/T nets with a delay added to the transi-
tion. In Systems Biology rates are given for reactions and are held in the <KineticLaw>
eld (where available) in SBML les. The inverse of the rates can be mapped directly
to the delay. There is a an issue as to how best to apply the rates to accurately capture
the stochastic nature of biological systems (see section 4.2). An acceptable and usable
mapping [25], assuming the existence of an appropriate PNML stochastic Petri net type,
would proceed as follows. The <KineticLaw> eld is read with its Math-ML elds de-
scribing the rate law. With in this there will constants which will have to be obtained
from the <ListOfParameters> specied in the SBML le. From this information a
single rate constant can be created. This would be added to the <delay> eld of the
appropriate transitions. There may, however be a case for storing the rate as a series
of parameters, more like the original SBML le. This would be extremely benecial if
a series of experiments was to be run on a system, altering a single variable on each
run. For example, if temperature was one of the variables that made up a rate law, the
modelling of the effect of a change of temperature on the system would be greatly fa-
cilitated by having transition rates relative to a global temperature variable. This would
allow the user to change one variable rather than possibly hundreds of individual rates.
Current attempts at biological modelling with Petri nets are based on relating the
number of tokens on a place directly to the quantity of molecules present. This ap-
proach has produced some promising results but another possible view is to consider
places to either be marked or not, with a token being put on a network place once a
concentration of a molecule has reached some threshold concentration. The idea is to
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only consider a place marked if a particular molecular species is present in a signi-
cant enough concentration to have an affect in the system. This representation would
be particularly useful when investigating gene products and regulatory networks. For
example if a protein is expressed in high enough quantities it may cause a group of
genes to be expressed (a regulon). Here the exact concentration of the protein is not
important, just that it is above a threshold level. Such a methodology is naturally suited
to using safe Petri net models which benet from many strong results that simplify net
analysis [32]. Using this approach would also remove the need to spend time obtaining
accurate molecular quantities for each place, which may not even be available for some
SBML models. However it would be necessary to decide on the threshold levels and
give initial markings as appropriate in the translation from SBML.
3.3 Analysis of a Biological Pathway
A SBML representation of the Saccharomyces cerevisiae glycolysis pathway (Figure 2)
was converted to a PNML representation of a P/T net using a prototype tool based on
our mapping. For full details of this conversion, including the complete SBML le and
resulting PNML we refer the interested reader to [24]. We then considered analysing
the PNML model using a number of Petri net tools. We began by using the Petri net ker-
nel [12] to load the PNML. From the Petri net kernel an Integrated Net Analyzer (INA)
[26] readable version of the system was obtained. This model was given a preliminary
analysis in INA, looking for T-invariants and P-invariants. One P-invariants was discov-
ered, one relating to the tight coupling between BPG and NAD. No other P-invariants
were found. Fifteen T-invariants relating to the reversible reactions were found. Hence
we see how Petri net properties can be directly related to biological phenomena.
Although we have only considered P and T invariants here there are many other
interesting properties that may be useful to biologists. We now discuss how some of
these Petri net properties can be related to biological systems.
– Deadlock. Deadlock would at the holistic level represent the death of the organism.
Deadlock in smaller systems or sub models would represent a pathway no longer
available to the organism, for example the lack of a resource would lead to deadlock
in that pathway and an alternative pathway utilised.
– Boundedness. A particular molecule may be toxic, lethal to the organism at a certain
level. Alternatively a molecule may induce further reactions at a certain threshold.
Hence, boundedness analysis would be able to check if these conditions occur from
an initial marking.
– Traps. A trap is a set of places which, once marked never loses all tokens. In biology
this could for example represent a persistent protein or metabolite, i.e. one with no
degradation pathway.
– Siphons. The presence of a siphon in a biological Petri net would indicate a store of
proteins or metabolites that have no way of being replenished. For example these
could be metabolites that are no longer available in a particular environment.
– Reachability. Reachability is potentially very interesting to biologists. By system-
atically deleting places from the net (the equivalent of a biological knock out exper-
iment) the biologist may be able to nd key genes that prevent certain states from
occurring.
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There are undoubtedly many other biological analogies in Petri net properties that could
be exploited using analysis techniques such as model checking. Further research is
needed to fully investigate this avenue in Systems Biology.
4 Proposals and Discussion
In this section we discuss the insights gained during our research on PNML and propose
some ideas for enhancing PNML as an interdisciplinary research tool in new elds such
as Systems Biology. We consider various aspects of PNML including timing issues,
graphical layout, modularity concepts, and data management issues.
4.1 Data Management Facilities
The work discussed in this paper exposes what we believe is a shortcoming in the cur-
rent version of PNML: the absence of data management facilities. Petri Net models
often form part of a larger overall project, where it is necessary to trace its evolution
through the use of version management and data management tools. We, for exam-
ple, would wish to trace the source of the original SBML model from the PNML ver-
sion produced, which would allow us to trust the data used in the model. The fact that
PNML allows embedded tool specic information (e.g., stochastic code such as used
by the Mobius tool [2]) makes it also imperative that extra information can be added to
a PNML le to identify that information in detail.
We propose that every PNML le should have a compulsory (but possibly empty)
header, to be used to deposit this kind of information (the importance of such features
has previously been recognised in the design of interchange formats such as EDIF [5]).
This could include (but should not necessarily be limited to) the following kind of data:
– the version number of the PNML language used in the le.
– the version number of the design contained in the le, as specied by the designer
of the net or the tool that produced it. This could be part of a more elaborate version
control string, maintained by the tool(s) used to control the overall project.
– the name of the tool that generated the net, with its version number.
– the data origin, which identies where the net was created, possibly including a
version number. This would be useful when the model is part of a project dispersed
over many geographical locations.
– the designer(s) of the net.
– a time stamp, to identify when the net was written. The format of this could be a
UTC (universal time coordinate).
– the name of the net.
– a set of annotation strings, to be displayed alongside the net.
– the names of les which contain libraries of already completed nets, to be included
in the current net. The order in which the names are specied is relevant.
If the net contains tool specic code, it should be possible to provide similar data for
each of those tools.
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4.2 Time Issues
At present PNML only deals with straightforward P/T nets and no standards exist for
other types of Petri nets such as stochastic Petri nets. Our work highlights how im-
portant it is to develop such Petri net type standards if PNML is to be accepted as an
interdisciplinary tool. For example, stochastic Petri nets have already been shown to be
useful in modelling biological systems [4,25] and it would have been natural to extend
our mapping to this type of net. However, the lack of any PNML stochastic net type
prevented us from undertaking this work in practice. Thus to facilitate the transfer of
other formalisms to PNML it is essential that the full range of Petri net types is avail-
able. The inclusion of timing information is an important issue in its own right and it
may well be desirable to augment PNML with a standard way of recording rate and
delay information which is not tool specic.
An Achilles heel in biological modelling at present is a lack of reliable rate constants
for all events in the system [18]. It is important that such practical limitation do not
prevent a stochastic net being stored and analysed. It would therefore be advantageous
for any time based PNML net to accept models where timing information is missing or
unreliable for some transitions. It may useful to provide a means for biologists to record
a best guess rate or a bound on the rates.
4.3 Graph Placement
The PNML standard specications propose the inclusion of a number of features con-
cerned with graphical information, layout and structure of Petri net models. This infor-
mation is not necessary for the theoretical view of the model, but is mandatory if PNML
is to be used in a large number of tools. Whilst these graphical features are valuable in-
clusions, features directly corresponding to these are missing from the SBML level 2
specication. This means that PNML models constructed automatically from biological
models may not have any layout information available and so a layout procedure must
be carried out prior to tool analysis.
It is feasible that a conversion process from SBML to PNML could involve the
generation of layout data from information derived from the connectivity of components
inherent in the SBML model, in combination with information from specic SBML
components such as compartments. In addition specic data about SBML components
derived from external sources such as the Gene Ontology [6], may also provide a means
to add layout features to structured PNML during the mapping process. However, if
PNML is to be used as a truly interdisciplinary interchange standard then it must also
address this problem by providing appropriate tags and tools for the default layout of
a Petri net. Work is currently underway at Newcastle to produce a tool which uses
heuristics to automatically augment PNML models with appropriate layout information.
4.4 Modularity and Composition
Biological systems typically contain a number of recurring sub-pathways which are
common to many different entities in that system. For example, each expressed gene
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that encodes a protein involved in a particular pathway is subject to transcription (a sep-
arate process) and the mRNA that results is interpreted by the translational processes of
the cell. Many components of the transcriptional and translational pathways are com-
monly applied to each gene. Variations in the application of different instances of these
sub-pathways between different genes often can be mapped through to differences in the
kinetic parameters that are applied to the steps in the pathway (e.g. promoter strength)
[25]. The ability to have ’standard’ or default sub-models such as these would facilitate
the rapid construction of large networks. Biologists often view such sub-pathways at
different levels of abstraction and then use the appropriate one depending on the detail
needed for a particular analysis. This approach allows biologists to update the sub-
pathways as they gain more knowledge and understanding of the processes involved.
Although at present SBML does not support the above view of biological systems re-
cent proposals for extending SBML have included the idea of a compositional approach
(see [23]). To cope with the above compositional view we need to be able to build
PNML models in a modular way allowing different PNML modules to represent the
various recurring parts and views of a biological system. It will therefore be vital that a
modular version of PNML, such as modular PNML [13], is available and supported to
aid translation of biological models to PNML. Using a modular approach would also
allow PNML models to be efciently maintained and manipulated, and allow different
abstract views of a biological system to be used. Providing modular concepts in PNML
would also aid the composition of interconnected biological systems. For example, reg-
ulatory systems can be articially viewed at the gene network level or at the protein
network level, and composing such views is an important modelling problem.
5 Conclusions
In this paper we have considered using Petri net and XML techniques to model and
analyse biological systems. We presented a scheme for automatically translating SBML
models of biological systems into PNML and developed a prototype tool to implement
this mapping. We illustrated our ideas using a SBML description of the Saccharomyces
cerevisiae glycolysis pathway which was translated into PNML and then analysed using
various Petri net tools.
This work has demonstrated how XML technologies can be used to open up new
and productive links between different research communities which have their own data
repositories and analysis tools. In particular, we have detailed how Petri net techniques
and tools can be used to analyse biological systems and our work can be seen as pro-
viding further evidence of the usefulness of Petri nets as a modelling and analysis tool
in Systems Biology.
XML technologies such as PNML and SBML are still developing and continued
work is needed to rene these standards to enhance interdisciplinary model exchange.
We have discussed the insights we have gained during our work and proposed a number
of areas for consideration to enhance the use of PNML. These included a discussion of
timing issues and the need to cope with partial or noisy information, as is often found in
biological models. We also considered the problem of graphical layout for automatically
generated PNML models and noted the need for additional tool support which we are
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currently investigating and developing. Other important issues discussed included the
need for modularity and encapsulation of traceability information for a PNML model.
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6 Appendix
Here the XML for both the input(SBML) and the output(PNML) of the tool are pre-
sented. The original PNML was obtained from the SBML website[23], and related to
the work published in [27]. This was modied slightly by removing the kinetic rates for
brevity.
6.1 Glycolysis SBML listing
<?xml version="1.0" encoding="UTF-8"?>
<!-- Created by Gepasi 3.30 on March 14, 2003, 13:42 -->
<sbml xmlns="http://www.sbml.org/sbml/level1" level="1" version="1">
<model name="Teusink">
<listOfCompartments>
<compartment name="uVol" volume="1"/>
</listOfCompartments>
<listOfSpecies>
<specie name="GLCi" compartment="uVol" initialAmount="0.08" boundaryCondition="false"/>
<specie name="G6P" compartment="uVol" initialAmount="1.39" boundaryCondition="false"/>
<specie name="F6P" compartment="uVol" initialAmount="0.28" boundaryCondition="false"/>
<specie name="F16P" compartment="uVol" initialAmount="0.1" boundaryCondition="false"/>
<specie name="TRIO" compartment="uVol" initialAmount="5.17" boundaryCondition="false"/>
<specie name="BPG" compartment="uVol" initialAmount="0" boundaryCondition="false"/>
<specie name="P3G" compartment="uVol" initialAmount="0.1" boundaryCondition="false"/>
<specie name="P2G" compartment="uVol" initialAmount="0.1" boundaryCondition="false"/>
<specie name="PEP" compartment="uVol" initialAmount="0.1" boundaryCondition="false"/>
<specie name="PYR" compartment="uVol" initialAmount="3.36" boundaryCondition="false"/>
<specie name="ACE" compartment="uVol" initialAmount="0.04" boundaryCondition="false"/>
<specie name="Pi" compartment="uVol" initialAmount="5" boundaryCondition="false"/>
<specie name="NAD" compartment="uVol" initialAmount="1.2" boundaryCondition="false"/>
<specie name="NADH" compartment="uVol" initialAmount="0.39" boundaryCondition="false"/>
<specie name="Glyc" compartment="uVol" initialAmount="0" boundaryCondition="true"/>
<specie name="Trh" compartment="uVol" initialAmount="0" boundaryCondition="true"/>
<specie name="CO2" compartment="uVol" initialAmount="1" boundaryCondition="true"/>
<specie name="SUCC" compartment="uVol" initialAmount="0" boundaryCondition="true"/>
<specie name="GLCo" compartment="uVol" initialAmount="50" boundaryCondition="true"/>
<specie name="ETOH" compartment="uVol" initialAmount="50" boundaryCondition="true"/>
<specie name="GLY" compartment="uVol" initialAmount="0.15" boundaryCondition="true"/>
</listOfSpecies>
<listOfReactions>
<reaction name="vGLK" reversible="true">
<listOfReactants>
<specieReference specie="GLCi" stoichiometry="1"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfReactants>
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<listOfProducts>
<specieReference specie="G6P" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vPGI" reversible="true">
<listOfReactants>
<specieReference specie="G6P" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="F6P" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vGLYCO" reversible="true">
<listOfReactants>
<specieReference specie="G6P" stoichiometry="1"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="Glyc" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vTreha" reversible="true">
<listOfReactants>
<specieReference specie="G6P" stoichiometry="2"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="Trh" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vPFK" reversible="true">
<listOfReactants>
<specieReference specie="F6P" stoichiometry="1"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="F16P" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vALD" reversible="true">
<listOfReactants>
<specieReference specie="F16P" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="TRIO" stoichiometry="2"/>
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</listOfProducts>
</reaction>
<reaction name="vGAPDH" reversible="true">
<listOfReactants>
<specieReference specie="TRIO" stoichiometry="1"/>
<specieReference specie="NAD" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="BPG" stoichiometry="1"/>
<specieReference specie="NADH" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vPGK" reversible="true">
<listOfReactants>
<specieReference specie="BPG" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="P3G" stoichiometry="1"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vPGM" reversible="true">
<listOfReactants>
<specieReference specie="P3G" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="P2G" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vENO" reversible="true">
<listOfReactants>
<specieReference specie="P2G" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="PEP" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vPYK" reversible="true">
<listOfReactants>
<specieReference specie="PEP" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="PYR" stoichiometry="1"/>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfProducts>
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</reaction>
<reaction name="vPDC" reversible="true">
<listOfReactants>
<specieReference specie="PYR" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="ACE" stoichiometry="1"/>
<specieReference specie="CO2" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vSUC" reversible="true">
<listOfReactants>
<specieReference specie="ACE" stoichiometry="2"/>
<specieReference specie="NAD" stoichiometry="3"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="NADH" stoichiometry="3"/>
<specieReference specie="SUCC" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vGLT" reversible="true">
<listOfReactants>
<specieReference specie="GLCo" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="GLCi" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vADH" reversible="true">
<listOfReactants>
<specieReference specie="ACE" stoichiometry="1"/>
<specieReference specie="NADH" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="NAD" stoichiometry="1"/>
<specieReference specie="ETOH" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vG3PDH" reversible="true">
<listOfReactants>
<specieReference specie="TRIO" stoichiometry="1"/>
<specieReference specie="NADH" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="NAD" stoichiometry="1"/>
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<specieReference specie="GLY" stoichiometry="1"/>
</listOfProducts>
</reaction>
<reaction name="vATP" reversible="true">
<listOfReactants>
<specieReference specie="Pi" stoichiometry="1"/>
</listOfReactants>
<listOfProducts>
<specieReference specie="CO2" stoichiometry="1"/>
</listOfProducts>
</reaction>
</listOfReactions>
</model>
</sbml>
6.2 Converted PNML listing
<?xml version="1.0" encoding="UTF-8"?>
<pnml>
<net id="Teusink" type="http://www.informatik.hu-berlin.de/top/pntd/ptNetb" />
<place ID="PEP">
<name>
<text>PEP</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="TRIO">
<name>
<text>TRIO</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="GLCo">
<name>
<text>GLCo</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
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</place>
<place ID="Trh">
<name>
<text>Trh</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="ETOH">
<name>
<text>ETOH</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="P3G">
<name>
<text>P3G</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="NADH">
<name>
<text>NADH</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="GLCi">
<name>
<text>GLCi</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="F16P">
<name>
<text>F16P</text>
</name>
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<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="BPG">
<name>
<text>BPG</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="GLY">
<name>
<text>GLY</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="ACE">
<name>
<text>ACE</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="F6P">
<name>
<text>F6P</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="Glyc">
<name>
<text>Glyc</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="SUCC">
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<name>
<text>SUCC</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="P2G">
<name>
<text>P2G</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="PYR">
<name>
<text>PYR</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="NAD">
<name>
<text>NAD</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="CO2">
<name>
<text>CO2</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<place ID="G6P">
<name>
<text>G6P</text>
</name>
<initialMarking>
<text>0</text>
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</initialMarking>
</place>
<place ID="Pi">
<name>
<text>Pi</text>
</name>
<initialMarking>
<text>0</text>
</initialMarking>
</place>
<Transition ID="vPFK">
<name>
<text>vPFK</text>
</name>
</Transition>
<Transition ID="vGAPDHReverse">
<name>
<text>vGAPDHReverse</text>
</name>
</Transition>
<Transition ID="vGLK">
<name>
<text>vGLK</text>
</name>
</Transition>
<Transition ID="vADH">
<name>
<text>vADH</text>
</name>
</Transition>
<Transition ID="vPGM">
<name>
<text>vPGM</text>
</name>
</Transition>
<Transition ID="vPGKReverse">
<name>
<text>vPGKReverse</text>
</name>
</Transition>
<Transition ID="vPGIReverse">
<name>
<text>vPGIReverse</text>
</name>
</Transition>
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<Transition ID="vPGK">
<name>
<text>vPGK</text>
</name>
</Transition>
<Transition ID="vATP">
<name>
<text>vATP</text>
</name>
</Transition>
<Transition ID="vPDCReverse">
<name>
<text>vPDCReverse</text>
</name>
</Transition>
<Transition ID="vPGI">
<name>
<text>vPGI</text>
</name>
</Transition>
<Transition ID="vG3PDHReverse">
<name>
<text>vG3PDHReverse</text>
</name>
</Transition>
<Transition ID="vPYKReverse">
<name>
<text>vPYKReverse</text>
</name>
</Transition>
<Transition ID="vPYK">
<name>
<text>vPYK</text>
</name>
</Transition>
<Transition ID="vTreha">
<name>
<text>vTreha</text>
</name>
</Transition>
<Transition ID="vPDC">
<name>
<text>vPDC</text>
</name>
</Transition>
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<Transition ID="vGLTReverse">
<name>
<text>vGLTReverse</text>
</name>
</Transition>
<Transition ID="vTrehaReverse">
<name>
<text>vTrehaReverse</text>
</name>
</Transition>
<Transition ID="vENO">
<name>
<text>vENO</text>
</name>
</Transition>
<Transition ID="vGLKReverse">
<name>
<text>vGLKReverse</text>
</name>
</Transition>
<Transition ID="vALDReverse">
<name>
<text>vALDReverse</text>
</name>
</Transition>
<Transition ID="vENOReverse">
<name>
<text>vENOReverse</text>
</name>
</Transition>
<Transition ID="vGLYCOReverse">
<name>
<text>vGLYCOReverse</text>
</name>
</Transition>
<Transition ID="vG3PDH">
<name>
<text>vG3PDH</text>
</name>
</Transition>
<Transition ID="vADHReverse">
<name>
<text>vADHReverse</text>
</name>
</Transition>
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<Transition ID="vSUCReverse">
<name>
<text>vSUCReverse</text>
</name>
</Transition>
<Transition ID="vGAPDH">
<name>
<text>vGAPDH</text>
</name>
</Transition>
<Transition ID="vPFKReverse">
<name>
<text>vPFKReverse</text>
</name>
</Transition>
<Transition ID="vPGMReverse">
<name>
<text>vPGMReverse</text>
</name>
</Transition>
<Transition ID="vGLT">
<name>
<text>vGLT</text>
</name>
</Transition>
<Transition ID="vALD">
<name>
<text>vALD</text>
</name>
</Transition>
<Transition ID="vATPReverse">
<name>
<text>vATPReverse</text>
</name>
</Transition>
<Transition ID="vSUC">
<name>
<text>vSUC</text>
</name>
</Transition>
<Transition ID="vGLYCO">
<name>
<text>vGLYCO</text>
</name>
</Transition>
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<arc ID="a0" source="F6P" target="vPFK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a1" source="Pi" target="vPFK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a2" source="BPG" target="vGAPDHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a3" source="NADH" target="vGAPDHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a4" source="GLCi" target="vGLK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a5" source="Pi" target="vGLK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a6" source="ACE" target="vADH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a7" source="NADH" target="vADH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a8" source="P3G" target="vPGM">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a9" source="P3G" target="vPGKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a10" source="Pi" target="vPGKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a11" source="F6P" target="vPGIReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a12" source="BPG" target="vPGK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a13" source="Pi" target="vATP">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a14" source="ACE" target="vPDCReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a15" source="CO2" target="vPDCReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a16" source="G6P" target="vPGI">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a17" source="NAD" target="vG3PDHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
30
<arc ID="a18" source="GLY" target="vG3PDHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a19" source="PYR" target="vPYKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a20" source="Pi" target="vPYKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a21" source="PEP" target="vPYK">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a22" source="G6P" target="vTreha">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a23" source="Pi" target="vTreha">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a24" source="PYR" target="vPDC">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a25" source="GLCi" target="vGLTReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a26" source="Trh" target="vTrehaReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a27" source="P2G" target="vENO">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a28" source="G6P" target="vGLKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a29" source="TRIO" target="vALDReverse">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a30" source="PEP" target="vENOReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a31" source="Glyc" target="vGLYCOReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a32" source="TRIO" target="vG3PDH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a33" source="NADH" target="vG3PDH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a34" source="NAD" target="vADHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a35" source="ETOH" target="vADHReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a36" source="NADH" target="vSUCReverse">
<inscription>
<text>3</text>
</inscription>
</arc>
<arc ID="a37" source="SUCC" target="vSUCReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a38" source="TRIO" target="vGAPDH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a39" source="NAD" target="vGAPDH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a40" source="F16P" target="vPFKReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a41" source="P2G" target="vPGMReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a42" source="GLCo" target="vGLT">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a43" source="F16P" target="vALD">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a44" source="CO2" target="vATPReverse">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a45" source="ACE" target="vSUC">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a46" source="NAD" target="vSUC">
<inscription>
<text>3</text>
</inscription>
</arc>
<arc ID="a47" source="G6P" target="vGLYCO">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a48" source="Pi" target="vGLYCO">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a49" source="vPFK" target="F16P">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a50" source="vGAPDHReverse" target="TRIO">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a51" source="vGAPDHReverse" target="NAD">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a52" source="vGLK" target="G6P">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a53" source="vADH" target="NAD">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a54" source="vADH" target="ETOH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a55" source="vPGM" target="P2G">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a56" source="vPGKReverse" target="BPG">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a57" source="vPGIReverse" target="G6P">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a58" source="vPGK" target="P3G">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a59" source="vPGK" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a60" source="vATP" target="CO2">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a61" source="vPDCReverse" target="PYR">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a62" source="vPGI" target="F6P">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a63" source="vG3PDHReverse" target="TRIO">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a64" source="vG3PDHReverse" target="NADH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a65" source="vPYKReverse" target="PEP">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a66" source="vPYK" target="PYR">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a67" source="vPYK" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a68" source="vTreha" target="Trh">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a69" source="vPDC" target="ACE">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a70" source="vPDC" target="CO2">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a71" source="vGLTReverse" target="GLCo">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a72" source="vTrehaReverse" target="G6P">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a73" source="vTrehaReverse" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a74" source="vENO" target="PEP">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a75" source="vGLKReverse" target="GLCi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a76" source="vGLKReverse" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a77" source="vALDReverse" target="F16P">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a78" source="vENOReverse" target="P2G">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a79" source="vGLYCOReverse" target="G6P">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a80" source="vGLYCOReverse" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a81" source="vG3PDH" target="NAD">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a82" source="vG3PDH" target="GLY">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a83" source="vADHReverse" target="ACE">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a84" source="vADHReverse" target="NADH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a85" source="vSUCReverse" target="ACE">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a86" source="vSUCReverse" target="NAD">
<inscription>
<text>3</text>
</inscription>
</arc>
<arc ID="a87" source="vGAPDH" target="BPG">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a88" source="vGAPDH" target="NADH">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a89" source="vPFKReverse" target="F6P">
<inscription>
<text>1</text>
</inscription>
</arc>
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<arc ID="a90" source="vPFKReverse" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a91" source="vPGMReverse" target="P3G">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a92" source="vGLT" target="GLCi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a93" source="vALD" target="TRIO">
<inscription>
<text>2</text>
</inscription>
</arc>
<arc ID="a94" source="vATPReverse" target="Pi">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a95" source="vSUC" target="NADH">
<inscription>
<text>3</text>
</inscription>
</arc>
<arc ID="a96" source="vSUC" target="SUCC">
<inscription>
<text>1</text>
</inscription>
</arc>
<arc ID="a97" source="vGLYCO" target="Glyc">
<inscription>
<text>1</text>
</inscription>
</arc>
</pnml>
